NYSEARCA:RMED - NYSE Arca - US74933X3026 - Common Stock - Currency: USD
TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 90.00K | 14.00K | 22.00K | 259.00K | 1.27M | |||
Cost Of Goods | 76.00K | 161.00K | 1.56M | 2.17M | 4.13M | |||
Gross Profit | 14.00K | -147.00K | -1.54M | -1.91M | -2.86M | |||
Operating Expenses | 27.70M | 22.64M | 27.73M | 33.49M | 49.75M | |||
Research and Development | 3.52M | 6.39M | 12.25M | 8.96M | 4.45M | |||
Selling, General, and Administrative Expenses | 22.78M | 16.25M | 15.47M | 24.53M | 45.30M | |||
Operating Income | -27.68M | -22.79M | -29.27M | -35.40M | -52.61M | |||
Interest Income/Expense | N/A | N/A | N/A | 88.00K | 967.00K | |||
Other Income/Expense | 66.00K | 99.00K | -14.00K | N/A | 790.00K | |||
Non Recurring Items | -60.26M | -4.17M | 2.02M | N/A | N/A | |||
Income Before Taxes | -87.77M | -26.86M | -27.26M | -35.31M | -51.64M | |||
Income Tax | N/A | 3.00K | 4.00K | 7.00K | 15.00K | |||
Net Income | -88.57M | -26.86M | -25.07M | -36.05M | -56.96M | |||
EBITDA | -26.00M | -22.37M | -27.70M | -33.03M | -50.86M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -45.97 | -25.98 | -247.97 | -1.06K | -5.41K | |||
Non GAAP EPS | N/A | N/A | N/A | -1.58K | -5.42K | |||
Statistics | ||||||||
Gross Profit Margin | 15.56% | -1050.00% | -6990.91% | -738.61% | -224.67% | |||
Profit Margin | -98411.11% | -191892.86% | -113954.55% | -13916.99% | -4474.23% | |||
Operating Profit Margin | -30760.00% | -162778.57% | -133027.27% | -13668.34% | -4132.52% |
All data in USD